z-logo
open-access-imgOpen Access
Interventions for cancer-related pain
Author(s) -
Tao Xu,
Hanzhou Lei,
Yutong Zhang,
Siying Huang,
Ziwen Wang,
Siyuan Zhou,
Jing Yang,
Qianhua Zheng,
Jiao Chen,
Ling Zhao
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017844
Subject(s) - medicine , psychological intervention , medline , cancer pain , physical therapy , cancer , intensive care medicine , psychiatry , political science , law
Background: Several treatments are beneficial for patients with cancer-related pain (CRP), and there are numbers of systematic reviews evaluating the effectiveness and safety of these treatments. However, the overall quality of the evidence has not been quantitatively assessed. The aim of this study is to overcome the inconclusive evidence about the interventions of CRP. Methods: We will perform an umbrella systematic review to identify eligible randomised controlled trials (RCTs). A comprehensive literature search will be conducted in MEDLINE, EMBASE, and the Cochrane library for systematic reviews, meta-analyses and RCTs. We will describe the general information of the RCTs for participants, interventions, outcome measurements, comparisons, and results. Network meta-analysis will be developed to determine the comparative effectiveness of the treatments. Results: The result of this network meta-analysis will provide direct and indirect evidence of treatments for CRP. Conclusion: The conclusion of our study will help clinicians and CRP patients to choose suitable treatment options. Ethics and dissemination: Formal ethical approval is not required, as the data are not individualized. The findings of this systematic review will be disseminated in a peer-reviewed publication and/or presented at relevant conferences. PROSPERO registration number: CRD42019131721.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here